TICKETS FOR THE NBA CHINA GAMES 2026 PRESENTED BY TAOBAO 88VIP FEATURING THE DALLAS MAVERICKS AND HOUSTON ROCKETS TO GO ON SALE ON AUG. 12
Press Release

TICKETS FOR THE NBA CHINA GAMES 2026 PRESENTED BY TAOBAO 88VIP FEATURING THE DALLAS MAVERICKS AND HOUSTON ROCKETS TO GO ON SALE ON AUG. 12

– Mavericks and Rockets Will Play Preseason Games on Oct. 9 and 11 at The Venetian Arena in Macao – – Star-Studded Lineup of Artists from Across Asia to Perform at Games and NBA Fan Day – MACAO, Aug. 10, 2026 /PRNewswire/ — The National Basketball Association (NBA) and Sands China Ltd. (HKEx: 1928.HK) today announced […]

Read More
Traditional Martial Arts Showdown: Kungfu Elite from Home and Abroad Converge on Yongchun
Press Release

Traditional Martial Arts Showdown: Kungfu Elite from Home and Abroad Converge on Yongchun

QUANZHOU, China, Aug. 10, 2026 /PRNewswire/ —  A report from Hong Kong Commercial Daily: Photo by Chen Zhipeng On August 8, the gong sounded at Yongchun Dilan Gymnasium, marking the opening of the 2026 National Traditional Wushu Open (Yongchun White Crane Kungfu Division). Over 1,600 martial artists from 111 teams, domestic and international, have gathered […]

Read More
ADNOC Gas Delivers Resilient Q2 Net Income, Takes FID on Major Growth Projects
Press Release

ADNOC Gas Delivers Resilient Q2 Net Income, Takes FID on Major Growth Projects

Delivers net income of $665 million driven by domestic gas demandFinal Investment Decisions on Rich Gas Development project to drive 60% EBITDA growth by 2030Successfully accelerating Habshan recovery to 85%, ahead of scheduleQuarterly dividend of $940 million approved, with progressive dividend policy reaffirmed ABU DHABI, UAE, Aug. 10, 2026 /PRNewswire/ — ADNOC Gas plc and […]

Read More
SOHU.COM REPORTS SECOND QUARTER 2026 UNAUDITED FINANCIAL RESULTS
Press Release

SOHU.COM REPORTS SECOND QUARTER 2026 UNAUDITED FINANCIAL RESULTS

BEIJING, Aug 10, 2026 /PRNewswire/ — Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today reported unaudited financial results for the second quarter ended June 30, 2026. Second Quarter Highlights[1] Total revenues were US$136 million, up 7% year-over-year and down 4% quarter-over-quarter. Marketing services revenues […]

Read More
Manguning Hotels Advances Sustainable, Place-Led Hospitality Across Bali
Press Release

Manguning Hotels Advances Sustainable, Place-Led Hospitality Across Bali

BALI, Indonesia, Aug. 10, 2026 /PRNewswire/ — Manguning Hotels is strengthening its commitment to responsible tourism by participating in the Eco Climate Badge verification program by Eco Tourism Bali, an independent sustainability assessment for hospitality businesses aligned with recognized global tourism standards. Through assessment and on-site verification, the program helps hotels review their environmental practices and […]

Read More
Tencent Cloud Drives AI Adoption to Cultivate the Greater Bay Area's Next Generation of Digital Talent
Press Release

Tencent Cloud Drives AI Adoption to Cultivate the Greater Bay Area's Next Generation of Digital Talent

Through AI platform tools such as CodeBuddy and WorkBuddy, Tencent Cloud is helping young people build their own "future teams", unlock their innovation potential, and seize opportunities in the AI era HONG KONG, Aug. 10, 2026 /PRNewswire/ — Tencent Cloud, the cloud business under Tencent, highlighted at the 8th Guangdong-Hong Kong-Macao Greater Bay Area Youth […]

Read More
Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer
Press Release

Akeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer

HONG KONG, Aug. 10, 2026 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the "Company")  announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company’s internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (bsADC), in combination with ivonescimab (the Company’s PD-1/VEGF bispecific antibody), for the treatment of advanced breast cancer. […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.